These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 26749399
1. Anticipatory Behavior in Response to Medicare Part D's Coverage Gap. Kaplan CM, Zhang Y. Health Econ; 2017 Mar; 26(3):338-351. PubMed ID: 26749399 [Abstract] [Full Text] [Related]
2. Impact of cost sharing on prescription drugs used by Medicare beneficiaries. Goedken AM, Urmie JM, Farris KB, Doucette WR. Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109 [Abstract] [Full Text] [Related]
3. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase. Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC. J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080 [Abstract] [Full Text] [Related]
4. The January effect: medication reinitiation among Medicare Part D beneficiaries. Kaplan C, Zhang Y. Health Econ; 2014 Nov; 23(11):1287-300. PubMed ID: 23943539 [Abstract] [Full Text] [Related]
5. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs. Hwang TJ, Jain N, Lauffenburger JC, Vokinger KN, Kesselheim AS. JAMA Intern Med; 2019 Mar 01; 179(3):374-380. PubMed ID: 30640379 [Abstract] [Full Text] [Related]
6. The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure. Baik SH, Rollman BL, Reynolds CF, Lave JR, Smith KJ, Zhang Y. J Ment Health Policy Econ; 2012 Sep 01; 15(3):105-18. PubMed ID: 23001279 [Abstract] [Full Text] [Related]
7. Digesting the doughnut hole. Joyce GF, Zissimopoulos J, Goldman DP. J Health Econ; 2013 Dec 01; 32(6):1345-55. PubMed ID: 24308883 [Abstract] [Full Text] [Related]
9. Medicare Part D and quality of prescription medication use in older adults. Lau DT, Briesacher BA, Touchette DR, Stubbings J, Ng JH. Drugs Aging; 2011 Oct 01; 28(10):797-807. PubMed ID: 21970307 [Abstract] [Full Text] [Related]
12. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25. Cline RR, Worley MM, Schondelmeyer SW, Schommer JC, Larson TA, Uden DL, Hadsall RS. Res Social Adm Pharm; 2010 Jun 01; 6(2):130-42. PubMed ID: 20511112 [Abstract] [Full Text] [Related]
14. Demand for prescription drugs under non-linear pricing in Medicare Part D. Jung K, Feldman R, McBean AM. Int J Health Care Finance Econ; 2014 Mar 01; 14(1):19-40. PubMed ID: 24214101 [Abstract] [Full Text] [Related]
16. Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression. Zhang Y, Baik SH, Zhou L, Reynolds CF, Lave JR. Arch Gen Psychiatry; 2012 Jul 01; 69(7):672-9. PubMed ID: 22752233 [Abstract] [Full Text] [Related]
17. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement. Yala SM, Duru OK, Ettner SL, Turk N, Mangione CM, Brown AF. BMC Health Serv Res; 2014 Dec 20; 14():665. PubMed ID: 25526892 [Abstract] [Full Text] [Related]
18. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit. Patel RA, Walberg MP, Tong E, Tan F, Rummel AE, Woelfel JA, Carr-Lopez SM, Galal SM. J Manag Care Spec Pharm; 2014 Mar 20; 20(3):283-90. PubMed ID: 24564812 [Abstract] [Full Text] [Related]
19. Effect of an expenditure cap on low-income seniors' drug use and spending in a state pharmacy assistance program. Bishop CE, Ryan AM, Gilden DM, Kubisiak J, Thomas CP. Health Serv Res; 2009 Jun 20; 44(3):1010-28. PubMed ID: 19291168 [Abstract] [Full Text] [Related]